| Dr Vicki Miller Neace, PHARMD | |
|
100 Emancipation Dr, Suite 119, Hampton, VA 23667-0001 | |
| (757) 722-9961 | |
| Not Available |
| Full Name | Dr Vicki Miller Neace |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 100 Emancipation Dr, Hampton, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033168158 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 0202206886 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vicki Miller Neace, PHARMD 11 Knodishall Way, Hampton, VA 23664-1967 Ph: (757) 224-3896 | Dr Vicki Miller Neace, PHARMD 100 Emancipation Dr, Suite 119, Hampton, VA 23667-0001 Ph: (757) 722-9961 |
News Archive
The overall wellbeing of U.S. children has increased by nearly 10% from 1994 to 2006 despite increased rates of childhood obesity and low-birthweight babies, according to a study released on Thursday, the Washington Post reports.
The torrential rains that began in June in West Africa and subsequent floods have forced an estimated 150,000 people from their homes and claimed the lives of 160, VOA News reports. The worst affected countries include Senegal, Burkina Faso, Ghana, Niger and Sierra Leone (Schlein, 9/13).
Many older, but also increasingly younger, people suffer from several diseases at the same time. Scientists at the Berlin Institute of Health at Charité – Universitätsmedizin Berlin, together with colleagues from Munich and the United Kingdom, have now identified common risk factors that predispose to multiple even seemingly unrelated diseases.
A team of researchers from the Massachusetts General Hospital Center for Engineering in Medicine (MGH-CEM) has developed a novel approach that dramatically simplifies the evaluation of the liver's drug-metabolizing activity and the potential toxic effects of the products of that activity on other organs.
OSI Pharmaceuticals, Inc. has announced further results from the Phase III SATURN study showing that Tarceva® (erlotinib) extended the survival of patients with advanced non-small cell lung cancer (NSCLC) when used as single agent, maintenance therapy in patients who did not progress following first-line treatment with platinum-based chemotherapy.
› Verified 9 days ago
Sharita Holmes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 401 E Mercury Blvd, Hampton, VA 23663 Phone: 757-728-3524 Fax: 757-728-3529 | |
Lyz Darmeys Estrada, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4813 W Mercury Blvd, Hampton, VA 23666 Phone: 757-826-2792 | |
Mrs. Monica Rhena Miller, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 Fax: 757-728-6054 | |
Dr. Morgan Searcy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4813 W Mercury Blvd, Hampton, VA 23666 Phone: 757-826-2792 | |
Dr. Michael L. Deangelo, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 Emancipation Dr, Hampton, VA 23667 Phone: 757-722-9961 | |
Dr. Monique Sharaye White, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 670 Downey Green St, Apartment 226, Hampton, VA 23666 Phone: 757-838-0162 Fax: 757-728-6796 |